Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Interest & Investment Income (2020 - 2024)

Historic Interest & Investment Income for Silence Therapeutics (SLN) over the last 5 years, with Q3 2024 value amounting to $1.3 million.

  • Silence Therapeutics' Interest & Investment Income fell 5081.82% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.1 million, marking a year-over-year increase of 25350.77%. This contributed to the annual value of $1.8 million for FY2023, which is 1400.47% up from last year.
  • Per Silence Therapeutics' latest filing, its Interest & Investment Income stood at $1.3 million for Q3 2024, which was down 5081.82% from $1.3 million recorded in Q2 2024.
  • Silence Therapeutics' 5-year Interest & Investment Income high stood at $189.7 million for Q3 2020, and its period low was -$4.8 million during Q4 2022.
  • Its 5-year average for Interest & Investment Income is $11.7 million, with a median of $425463.5 in 2023.
  • Examining YoY changes over the last 5 years, Silence Therapeutics' Interest & Investment Income showed a top increase of 115028.85% in 2022 and a maximum decrease of 1980333.77% in 2022.
  • Quarter analysis of 5 years shows Silence Therapeutics' Interest & Investment Income stood at $290499.2 in 2020, then plummeted by 91.65% to $24264.2 in 2021, then crashed by 19803.34% to -$4.8 million in 2022, then skyrocketed by 110.07% to $481566.9 in 2023, then skyrocketed by 164.68% to $1.3 million in 2024.
  • Its last three reported values are $1.3 million in Q3 2024, $1.3 million for Q2 2024, and -$1.0 million during Q1 2024.